The triple-negative breast cancer subtype (i.e., negative for estrogen and progesterone receptors and HER2, ER-PR-HER2-) is overrepresented in IBC, comprising 25–30% of cases [9, 10]. The gene discussed is PGR; the disease is triple-negative breast carcinoma.